Excellent post Michael, there is no doubt in my mind that this study from the 'American Journal of Infection Control' will be a major piece of Nanosonic's Trophon marketing dossier going forward.... There are many many incentives for hospitals to use the Trophon and many many disincentives to not use it, major litigation being just one.
AJIC......NAN June 2018, page-2
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$3.23 |
Change
0.110(3.53%) |
Mkt cap ! $978.6M | |||
| Open | High | Low | Value | Volume |
| $3.16 | $3.25 | $3.14 | $4.288M | 1.334M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 7081 | $3.19 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $3.23 | 8306 | 1 |
View Market Depth
| Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
| NAN (ASX) Chart |